| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |